BCIQ Profiles

Company Profile Report

Takeda proposes divestment of Shire GI candidate, announces loans

Takeda Pharmaceutical Co. Ltd. (Tokyo:4502) said it proposed to the European Commission a potential divestment of Crohn’s disease and ulcerative colitis candidate SHP647 once it

Read the full 259 word article

How to gain access

Continue reading with a
two-week free trial.